Live and On-Demand Webinars:

2nd Consensus Conference on Safety of Intravenous Drug Delivery Systems

The 2nd Consensus Conference on the Safety of Intravenous Drug Delivery was recently convened to reassess and prioritize the safety of available IV drug delivery systems. The proceedings from this conference were published in early 2009 in the American Journal of Health System Pharmacy. This program will review the key issues discussed at the conference and discuss the implications for pharmacists and pharmacy leaders. Specifically, the objectives are:

1. To review changes in the current IV delivery market that affect day-to-day practice and patient safety.
2. To briefly review the conference format and attendees.
3. To highlight the proceedings of the conference and the recommendations from the expert panel.
4. To discuss the resulting decision matrix and its application to day to day pharmacy practice.

Effective Pharmacy Interactions with "The C-Suite"
(with one minute preview)

1. Define and describe changing expectations for pharmacy services from the C-Suite.
2. Describe the current priorities for the C-Suite in order to understand them as an audience.
3. Anticipate questions that may arise when presenting to the C-Suite.
4. Begin to develop a presentation for the C-Suite by learning from the examples presented.

Healthcare Reform is "Still On the Table": Advocacy, Provisions and Implications for Hospital Pharmacy Practice

1. Discuss the provisions in the health care reform bill directly impacting health-system pharmacists
2. Identify ASHP's advocacy efforts to impact the health reform legislation
3. Define next steps and remaining hurdles toward recognition of pharmacists clinical services

How to Dialogue with C-Suite Executives

• Provide background information on the C-Suite
• Discuss ways to prepare for a C-Suite presentation
• Provide some helpful tips for presentations

ISMP Medication Safety Self Assessment® for Antithrombotic Therapy in Hospitals: Data Interpretation and Practice

1. Discuss the data submitted by hospitals completing the ISMP Medication Safety Self Assessment for Antithrombotic Therapy in Hospitals.
2. Assess responses to individual characteristics or statements within the 8 key areas of focus in the self assessment.
3. Discuss ISMP observed safety issues around antithrombotic therapy.

Managing Pharmaceutical Waste:
Strategies and Implementation

1. Provide a brief overview of regulations surrounding pharmaceutical waste.
2. Describe the benefits of a comprehensive waste disposal plan.
3. Differentiate between the different categories of pharmaceutical waste (i.e. U-listed and P-listed) and the implications for proper disposal of each category.
4. Define corresponding waste streams for pharmaceutical waste.
5. Provide 4 methodologies for developing a process for managing pharmaceutical waste at your institution.

Pharmacy Preparation for Next Flu Season: What You Need to Know

1. Explain the role of the pharmacy department in preparing for influenza season
2. Review the 2009-2010 influenza season including lessons learned to consider when planning for the upcoming season
3. Predict influenza vaccine inventory requirements for the institution
4. Discuss appropriate use of antiviral agents and reasons for not stockpiling the drugs at individual institutions
5. Discuss educational needs of both consumers and healthcare providers

Regulatory Issues Update: What Pharmacists Need to Know

1. Describe three regulatory issues of concern to health-system pharmacists recently addressed by the Centers for Medicare and Medicaid Services and/or the Food and Drug Administration
2. Explain the elements that may be included in a Risk Evaluation and Mitigation Strategy
3. Describe the status of the Centers for Medicare and Medicaid Services' National Drug Code reporting requirement

Statewide Disaster Preparedness for a Bioterrorism Attack: The Indiana Model

1. Identify and quantify medications required to support a large scale program targeted at covering "first responders" in a bioterror situation.
2. Summarize the unique elements that a partnership with a major drug wholesaler brings to this program.
3. Outline the elements that the National Pharmaceutical Stockpile provides to support these types of disasters.

The ASHP Safety Summit: Best Practices and Implications for Healthcare Providers

1. Describe the goals of ASHP's IV Safety Summit.
2. List the IV medications that most commonly cause harm according to data in one proprietary error reporting system.
3. Identify at least one major theme common to the safety practices recommended by Summit attendees.

The Minneapolis Bridge Collapse -
Lessons Learned on the Ground and the Big Picture

1. Identify pharmacy "Lessons Learned" from the Minneapolis Bridge Collapse experience
2. Describe roles that pharmacy can play in the ED during a disaster response
3. Describe changes to the hospital disaster plan that resulted from our experiences with the Minneapolis Bridge Collapse

USP 797: Insights and Resources for Small and Rural Hospitals

1. Describe what problems face small and rural hospitals in complying with USP 797
2. List the problems in order of priority, i.e. the order in which to solve the problems
3. Find sources for training materials, supplies and services for sterile compounding
4. Develop an approach to improving sterile compounding facilities
5. Set up a quality assurance and performance improvement program for sterile compounding